MedTrace Logo

Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

NCT04788966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2021-03-09

No results posted yet for this study

Summary

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Conditions

  • Diagnoses Disease

Interventions

DEVICE

the translation tool BabelDr

Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • University Hospital, Geneva

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2020-01-20
Completion
2020-01-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788966 on ClinicalTrials.gov